Zika virus (ZIKV) (strain Zika SPH2015) ZIKV-E / Envelope protein (Domain III, His Tag)

1/1
Price:
Size:
Number:

Zika virus (ZIKV) (strain Zika SPH2015) ZIKV-E / Envelope protein (Domain III, His Tag): 产品信息

纯度
> 90 % as determined by SDS-PAGE.
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
生物活性
Testing in progress
蛋白构建
A DNA sequence encoding the Zika virus (strain Zika SPH2015) E / Envelope (domain III) (ALU33341.1) (Val593-Lys699) was expressed with a polyhistidine tag at the C-terminus.
GenBank No.
表达宿主
HEK293 Cells
种属
ZIKV
预测 N 端
Val 593
分子量
The recombinant Zika virus (strain Zika SPH2015) E / Envelope (domain III) consists of 118 amino acids and predicts a molecular mass of 13 kDa.
缓冲液
Lyophilized from sterile PBS, pH 7.4.
1. Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
2. Please contact us for any concerns or special requirements.
Please refer to the specific buffer information in the hard copy of CoA.
运输方式
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.
Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
稳定性 & 储存条件
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃
Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
复溶
A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

Zika virus (ZIKV) (strain Zika SPH2015) ZIKV-E / Envelope protein (Domain III, His Tag): 图片

ZIKV Envelope 背景信息

Envelope of Zika virus is resposible for receptor binding and membrane. Analysis of the envelope protein of Zika, from Brazilian Zika SPH215 (KU321639), indicates predicted B and T cell epitopes in peptides that are consistent to those reported for dengue, YFYF and Japanese encephalitis. The envelope Domain II B cell epitope, to which much dengue non-neutralizing cross reaction is attributed, is also conserved also in Zika virus, consistent with prior field observations of cross reactivity with dengue and YF. Domain III of the Zika envelope protein, likely the main specific neutralizing domain, is distinct from recent Brazilian dengue isolates and a recent Peruvian YF isolate (GQ379163), 76% of possible major histocompatibility complex class (MHC) I and MHC II binding peptides and potential B cell linear epitopes are unique to Zika virus.
参考文献
    1. Marina Basarab specialty registrar. et al .Zika virus. BMJ 2016; 352:i1049 doi: 10.1136/bmj.i1049
    2. Pinto Júnior VL, et al. Zika virus: a review to clinicians, Acta Med Port 2015 Nov-Dec;28(6):760-765
    3. L Zammarchi, et al.Zika virus infection in a traveler returning to Europe from Brazil, March 2015
    4. Arturo Galindo-Fraga, et al. Zika virus: A new epidemic on our doorstep. Rev Inves Clin.2015, 67: 329-32
  • Deciphering Protein O-Glycosylation: Solid-Phase Chemoenzymatic Cleavage and Enrichment
    Author
    Yang, S;Onigman, P;Wu, WW;Sjogren, J;Nyhlen, H;Shen, RF;Cipollo, J;
    Year
    2018
    Journal
    Anal. Chem.
    Application
    O-glycosylation analysis
添加购物车成功! 添加购物车失败!请再次尝试 正在更新购物车,请稍后